Skip to Content

M D12 (Doxazosin Mesylate 8 mg)

Pill with imprint M D12 is Purple, Round and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Mylan Pharmaceuticals Inc..

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M D12

Doxazosin mesylate 8 mg M D12
Doxazosin mesylate 8 mg M D12  Front
Doxazosin mesylate 8 mg M D12  Back
Doxazosin mesylate 8 mg M D12
Doxazosin mesylate 8 mg M D12

Doxazosin Mesylate

Imprint:
M D12
Strength:
8 mg
Color:
Purple
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00378-4028 Mylan Pharmaceuticals Inc.
67544-0273 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide